Literature DB >> 23590542

Letter: dry blood spots for anti-TNF treatment monitoring in IBD.

N Vande Casteele, S Brecx, P Declerck, M Ferrante, P Rutgeerts, S Vermeire, A Gils.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23590542     DOI： 10.1111/apt.12283

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN： 0269-2813            Impact factor:   8.171


× No keyword cloud information.
  3 in total

Review 1.  Optimizing Biologic Agents in Ulcerative Colitis and Crohn's Disease.

Authors:  Aoibhlinn O'Toole; Alan C Moss
Journal:  Curr Gastroenterol Rep       Date:  2015-08

2.  Comparison of Point-of-Care and Classical Immunoassays for the Monitoring Infliximab and Antibodies Against Infliximab in IBD.

Authors:  Yara Nasser; Rémi Labetoulle; Ines Harzallah; Anne-Emmanuelle Berger; Xavier Roblin; Stephane Paul
Journal:  Dig Dis Sci       Date:  2018-06-09       Impact factor: 3.199

3.  Dried blood samples can support monitoring of infliximab concentrations in patients with inflammatory bowel disease: A clinical validation.

Authors:  Sophie E Berends; Geert R A M D'Haens; Tiny Schaap; Annick de Vries; Theo Rispens; Karien Bloem; Ron A A Mathôt
Journal:  Br J Clin Pharmacol       Date:  2019-05-11       Impact factor: 4.335
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.